Estimation of the underlying burden of pertussis in adolescents and adults in Southern Ontario, Canada

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  McGirr, Ashleigh A ^a   Tuite, Ashleigh R ^a   Fisman, David N ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

ADOLESCENT; ADULT; AGED; CALIBRATION; CANADA; CHILD; HUMAN; IMMUNOLOGY; INFANT; MIDDLE AGED; PRESCHOOL CHILD; REPRODUCIBILITY; STATISTICAL MODEL; UNCERTAINTY; VACCINATION; WHOOPING COUGH; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CALIBRATION; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MIDDLE AGED; MODELS, STATISTICAL; ONTARIO; PERTUSSIS VACCINE; REPRODUCIBILITY OF RESULTS; UNCERTAINTY; VACCINATION; WHOOPING COUGH; YOUNG ADULT;

EID: 84893455853     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083850     Document Type: Article

References (53)

1. Halperin SA (2008) Pertussis and Other Bordetella Infections. In: al Fe, editor. Harrison's Principles of Internal Medicine. 17 ed. New York: McGraw Hill Medical. pp. 933-937.
2. Van Boven M, Ferguson NM, Van Rie A (2004) Unveiling the burden of pertussis. Trends in Microbiology 12: 116-119. (Pubitemid 38314754)
3. Wood N, McIntyre P (2008) Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatric Respiratory Reviews 9: 201-212.
4. Crowcroft NS, Pebody RG (2006) Recent developments in pertussis. Lancet 367: 1926-1936. (Pubitemid 43831996)
5. World Health Organization (2003) WHO-recommended surveillance standard of pertussis. Available: http://www.who.int/immunization-monitoring/diseases/ pertussis-surveillance/en/. Accessed 2011 Jan 13.
6. Greenberg DP, Doemland M, Bettinger JA, Scheifele DW, Halperin SA, et al. (2009) Epidemiology of pertussis and haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis- inactivated poliovirus-haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tetanus-diphtheria-acellular pertussis vaccine: Implications for disease prevention in the United States. Pediatric Infectious Disease Journal 28: 521-528.
7. Smith C, Vyas H (2000) Early infantile pertussis; increasingly prevalent and potentially fatal. European Journal of Pediatrics 159: 898-900.
8. Winter K, Harriman K, Schechter R, Yamada E, Talarico J, et al. (2010) Pertussis - California, January-June 2010. Morbidity and Mortality Weekly Report 59: 817-818.
9. Barret AS, Ryan A, Breslin A, Cullen L, Murray A, et al. (2010) Pertussis outbreak in northwest Ireland, January - June 2010. Euro Surveill 15.
10. (2009) Communicable Diseases Report, NSW, November and December 2008. N S W Public Health Bull 20: 31-35.
11. Lavine JS, Bjornstad ON, de Blasio BF, Storsaeter J (2012) Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine. Vaccine 30: 544-551.
12. Blackwood JC, Cummings DA, Broutin H, Iamsirithaworn S, Rohani P (2013) Deciphering the impacts of vaccination and immunity on pertussis epidemiology in Thailand. Proc Natl Acad Sci U S A 110: 9595-9600.
13. Raguckas SE, VandenBussche HL, Jacobs C, Klepser ME (2007) Pertussis resurgence: Diagnosis, treatment, prevention, and beyond. Pharmacotherapy 27: 41-52.
14. Bamberger ES, Srugo I (2008) What is new in pertussis? European Journal of Pediatrics 167: 133-139.
15. Taranger J, Trollfors B, Lind L, Zackrisson G, Beling-Holmquist K (1994) Environmental contamination leading to false-positive polymerase chain reaction for pertussis [1]. Pediatric Infectious Disease Journal 13: 936-937. (Pubitemid 24322798)
16. Lievano FA, Reynolds MA, Waring AL, Ackelsberg J, Bisgard KM, et al. (2002) Issues associated with and recommendations for using PCR to detect outbreaks of pertussis. Journal of Clinical Microbiology 40: 2801-2805. (Pubitemid 35284944)
17. Brinig MM, Cummings CA, Sanden GN, Stefanelli P, Lawrence A, et al. (2006) Significant gene order and expression differences in Bordetella pertussis despite limited gene content variation. Journal of Bacteriology 188: 2375-2382.
18. Weir E (2002) Resurgence of Bordetella pertussis infection. Canadian Medical Association Journal 167: 1146.
19. Cherry JD (2003) The science and fiction of the "resurgence" of pertussis. Pediatrics 112: 405-406.
20. Mooi FR Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect Genet Evol 10: 36-49.
21. Wendelboe AM, Njamkepo E, Bourillon A, Floret DD, Gaudelus J, et al. (2007) Transmission of Bordetella pertussis to young infants. Pediatric Infectious Disease Journal 26: 293-299. (Pubitemid 46596651)
22. Halperin SA (2005) Canadian experience with implementation of an acellular pertussis vaccine booster-dose program in adolescents: implications for the United States. Pediatr Infect Dis J 24: S141-146.
23. Cherry JD (2005) The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 115: 1422-1427.
24. Arinaminpathy N, Lavine JS, Grenfell BT (2012) Self-boosting vaccines and their implications for herd immunity. Proc Natl Acad Sci U S A 109: 20154-20159.
25. Lavine JS, King AA, Bjornstad ON (2011) Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure. Proc Natl Acad Sci U S A 108: 7259-7264.
26. Stefanoff P, Paradowska-Stankiewicz IA, Lipke M, Karasek E, Rastawicki W, et al. (2013) Incidence of pertussis in patients of general practitioners in Poland. Epidemiol Infect: 1-10.
27. Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, et al. (2006) Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55: 1-34.
28. De Serres G (2000) An Advisory Committee Statement (ASC). National Advisory Committee on Immunization (NACI). Statement on adult/adolescent formulation of combined acellular pertussis, tetanus, and diphtheria vaccine. Can Commun Dis Rep 26: 1-8.
29. Macey R, Oster G, Zahley T (2000) Berkeley Madonna. Berkely, CA.
30. van Boven M, de Melker HE, Schellekens JF, Kretzschmar M (2000) Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in The Netherlands. Mathematical Biosciences 164: 161-182. (Pubitemid 30211015)
31. Preziosi MP, Halloran ME (2003) Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness. Vaccine 21: 1853-1861.
32. Tozzi AE, Rava L, Ciofi degli Atti ML, Salmaso S (2003) Clinical presentation of pertussis in unvaccinated and vaccinated children in the first six years of life. Pediatrics 112: 1069-1075. (Pubitemid 37339559)
33. Mossong J, Hens N, Jit M, Beutels P, Auranen K, et al. (2008) Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 5: e74.
34. Scheifele D, Spika J, Armstrong N, DeWals P, Halperin S, et al. (1997) An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI), STATEMENT ON PERTUSSIS VACCINE. Canada Communicable Disease Report 23.
35. Nguyen HT, Rohani P (2008) Noise, nonlinearity and seasonality: the epidemics of whooping cough revisited. J R Soc Interface 5: 403-413. (Pubitemid 351253065)
36. McWha L, MacArthur A, Badiani T, Schouten H, Tam T, et al. (2004) Measuring up: results from the National Immunization Coverage Survey, 2002. Can Commun Dis Rep 30: 37-50.
37. Ross MA (1932) The mortality in Ontario of four communicable diseases of childhood. Can Public Health J: 331-341.
38. Emerson H (1937) Measles and whooping cough: incidence, fatality, and death rates in thirty-two cities of the United States, in relation to administrative procedures intended for their control - 1924-1933. Am J Public Health 27: Supplement.
39. Macey R, Oster G, Zahley T (2009) Berkeley Madonna User's Guide. Berkely, CA: University of California.
40. Wearing HJ, Rohani P (2009) Estimating the duration of pertussis immunity using epidemiological signatures. PLoS Pathog 5: e1000647.
41. Wendelboe AM, Van Rie A, Salmaso S, Englund JA (2005) Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 24: S58-61. (Pubitemid 40676539)
42. Anderson RM, May RM (1990) Immunisation and herd immunity. Lancet 335: 641-645. (Pubitemid 20092661)
43. Fine PE (1993) Herd immunity: history, theory, practice. Epidemiol Rev 15: 265-302.
44. Wright SW, Edwards KM, Decker MD, Zeldin MH (1995) Pertussis infection in adults with persistent cough. JAMA 273: 1044-1046.
45. Wirsing von Konig CH, Postels-Multani S, Bock HL, Schmitt HJ (1995) Pertussis in adults: frequency of transmission after household exposure. Lancet 346: 1326-1329.
46. Broutin H, Viboud C, Grenfell BT, Miller MA, Rohani P (2010) Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries. Proc Biol Sci 277: 3239-3245.
47. Long SS, Welkon CJ, Clark JL (1990) Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J Infect Dis 161: 480-486. (Pubitemid 20107949)
48. Sutter RW, Cochi SL (1992) Pertussis hospitalizations and mortality in the United States, 1985-1988. Evaluation of the completeness of national reporting. JAMA 267: 386-391.
49. de Melker HE, Versteegh FG, Schellekens JF, Teunis PF, Kretzschmar M (2006) The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect 53: 106-113. (Pubitemid 44028673)
50. Halperin SA, Bortolussi R, MacLean D, Chisholm N (1989) Persistence of pertussis in an immunized population: results of the Nova Scotia Enhanced Pertussis Surveillance Program. J Pediatr 115: 686-693. (Pubitemid 19270256)
51. Orenstein WA, Douglas RG, Rodewald LE, Hinman AR (2005) Immunizations in the United States: success, structure, and stress. Health Aff (Millwood) 24: 599-610.
52. Schmitt HJ, vonKonig CHW, Neiss A, Bogaerts H, Bock HL, et al. (1996) Efficacy of acellular pertussis vaccine in early childhood after household exposure. Jama-Journal of the American Medical Association 275: 37-41. (Pubitemid 26004253)
53. Ward JI, Cherry JD, Chang S-J, Partridge S, Lee H, et al. (2005) Efficacy of an acellular pertussis vaccine among adolescents and adults. The New England journal of medicine 353: 1555-1563. (Pubitemid 41434634)